Haemonetics HAE
NYSE HAE
$118.50 +2.32 (+2.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Haemonetics (HAE) Gains from Sales and Divestitures (2009 - 2026)

Updated

Haemonetics (HAE) posted Gains from Sales and Divestitures of $178,000 for fiscal Q4 2026 (quarter ended Mar 28, 2026), down 84.2% from $1.13 million a year earlier and down 18.3% from the prior quarter.

Analysis

Haemonetics (HAE) Gains from Sales and Divestitures (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 28, 2026), Haemonetics' Gains from Sales and Divestitures came in at $714,000, down 95.5% from FY2025.

  • Annual Gains from Sales and Divestitures shows a five-year compound annual growth rate of -53.5% (FY2021 to FY2026).
  • In prior fiscal years, Haemonetics' Gains from Sales and Divestitures was $15.7 million in FY2025, $1.01 million in FY2024 (+7.4%), $943,000 in FY2023 (-90.2%) and $9.6 million in FY2022 (-70.7%).
  • Quarterly Gains from Sales and Divestitures has run from a low of $75,000 in fiscal Q2 2026 to a high of $14.1 million in fiscal Q1 2025 over five years.
  • On a year-over-year basis, Gains from Sales and Divestitures increased in three of the last seven quarters, with an average year-over-year change of 0.0%.
  • The strongest year-over-year quarter for Gains from Sales and Divestitures in the past five years was fiscal Q4 2025, with growth of 207.7%; the weakest was fiscal Q1 2026, with a decline of 98.3%.
  • According to Business Quant data, Gains from Sales and Divestitures for the three prior fiscal quarters was $218,000 (Q3 2026), $75,000 (Q2 2026) and $243,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.17 Bn 228.32 Bn 4.88 Bn
2 Abbott Laboratories 179.42 Bn 150.51 Bn 7.27 Bn
3 Danaher 161.98 Bn 145.80 Bn 3.61 Bn
4 Intuitive Surgical 156.76 Bn 137.18 Bn 2.08 Bn
5 Medtronic 122.13 Bn 88.00 Bn 6.34 Bn
6 Stryker 117.84 Bn 103.96 Bn 4.50 Bn
7 Boston Scientific 66.19 Bn 61.20 Bn 3.85 Bn
8 Becton Dickinson 54.16 Bn 51.31 Bn 2.32 Bn
9 Edwards Lifesciences 51.35 Bn 35.47 Bn 1.35 Bn
10 Haemonetics 5.39 Bn 4.26 Bn 202.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 28, 2026 178,000.00
Dec 27, 2025 218,000.00
Sep 27, 2025 75,000.00
Jun 28, 2025 243,000.00
Mar 29, 2025 1.13 Mn
Dec 28, 2024 160,000.00
Sep 28, 2024 312,000.00
Jun 29, 2024 14.10 Mn
Mar 30, 2024 366,000.00
Dec 30, 2023 203,000.00
Sep 30, 2023 230,000.00
Jul 1, 2023 214,000.00
Apr 1, 2023 561,000.00
Oct 1, 2022 382,000.00
Jul 3, 2021 9.60 Mn
Apr 3, 2021 199,000.00
Dec 26, 2020 1.12 Mn
Sep 26, 2020 31.50 Mn
Sep 28, 2019 8.08 Mn
Jul 1, 2017 8.00 Mn
API Access

Haemonetics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=HAE&period=max&api_key=YOUR_API_KEY